Showing results (211-220 of 234) with videos related to

Sort By:
Pageof 24
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptorK G Lloyd, S Arbilla, K Beaumont, et al.
Journal of Affective Disorders|May 20, 1999
Preclinical profile of befloxatone, a new reversible MAO-A inhibitorO Curet, G Damoiseau-Ovens, C Sauvage, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 1983
The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trialsK G Lloyd, P L Morselli, H Depoortere, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the ratB Scatton, K G Lloyd, B Zivkovic, et al.
Neuroscience|January 1, 1989
Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortexF Javoy-Agid, B Scatton, M Ruberg, et al.
Journal of Neural Transmission|January 1, 1988
Lack of correlation between DST results and urinary MHPG in depressed inpatientsH Lôo, M F Poirier, T Dennis, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemiaB Gotti, D Duverger, J Bertin, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1985
Non-benzodiazepine anxiolytics: potential activity of phenylpiperazines without 3H-diazepam displacing actionK G Lloyd, H Depoortere, B Scatton, et al.
Biological Psychiatry|August 1, 1986
Lack of correlation between plasma DOPEG and urinary MOPEG levels in depressed patientsH Lôo, T Dennis, J M Vanelle, et al.
Pageof 24